BioAtla, Inc. (BCAB) vs Cullinan Therapeutics, Inc. (CGEM)
Detailed comparison between BioAtla, Inc., Cullinan Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)Cullinan Therapeutics, Inc. (CGEM)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
Cullinan Therapeutics, Inc.
CGEM
| Metric | BioAtla, Inc. (BCAB) | Cullinan Therapeutics, Inc. (CGEM) |
|---|---|---|
| Current Price | $0.35 | $7.53 |
| Change | -0.02 (-5.02%) | -0.24 (-3.09%) |
| Market Cap | $0.02B | $0.44B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.24 | -2.32 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $2.52 | $21.01 |
| 52-Week Low | $0.24 | $6.85 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.22 | $-2.77 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | -12.22% | -30.30% | -79.29% | -98.87% | -98.87% | -98.87% |
| CGEM | -1.83% | -27.74% | -58.83% | -74.82% | -74.82% | -74.82% |